Reported 225,856 shares, up 95,105 (72.7%) from the prior quarter.
Reported value 84.3%; share count 72.7% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-03-31 | 459272 |
| 2023-06-30 | 0 |
| 2023-09-30 | 1285091 |
| 2023-12-31 | 3591228 |
| 2024-03-31 | 4258770 |
| 2024-06-30 | 2444912 |
| 2024-09-30 | 8430753 |
| 2024-12-31 | 10892754 |
| 2025-03-31 | 6490479 |
| 2025-06-30 | 11961333 |
| 2025-09-30 | 34961672 |
| 2025-12-31 | 59890625 |
| 2026-03-31 | 40911498 |
| 2026-06-30 | 7122593 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 97,383 | -542,459 (-84.8%) | < 0.01% | $7,122,593 | 2026-08-14 | |
| Q1 2026 | Reduced | 639,842 | -114,353 (-15.2%) | < 0.01% | $40,911,498 | 2026-05-15 | |
| Q4 2025 | Added | 754,195 | +225,114 (42.5%) | < 0.01% | $59,890,625 | 2026-02-10 | |
| Q3 2025 | Added | 529,081 | +303,225 (134.3%) | < 0.01% | $34,961,672 | 2025-11-14 | |
| Q2 2025 | Added | 225,856 | +95,105 (72.7%) | < 0.01% | $11,961,333 | 2025-08-14 | |
| Q1 2025 | Reduced | 130,751 | -41,059 (-23.9%) | < 0.01% | $6,490,479 | 2025-05-09 | |
| Q4 2024 | Added | 171,810 | +244 (0.1%) | < 0.01% | $10,892,754 | 2025-02-11 | |
| Q3 2024 | Added | 171,566 | +117,319 (216.3%) | < 0.01% | $8,430,753 | 2024-11-14 | |
| Q2 2024 | Reduced | 54,247 | -14,156 (-20.7%) | < 0.01% | $2,444,912 | 2024-08-13 | |
| Q1 2024 | Added | 68,403 | +6,228 (10.0%) | < 0.01% | $4,258,770 | 2024-05-15 | |
| Q4 2023 | Added | 62,175 | +34,821 (127.3%) | < 0.01% | $3,591,228 | 2024-02-13 | |
| Q3 2023 | New | 27,354 | +27,354 (0.0%) | < 0.01% | $1,285,091 | 2023-11-14 | |
| Q2 2023 | Reduced | 0 | -21,674 (-100.0%) | 0 | $0 | 2023-08-15 | |
| Q1 2023 | New | 21,674 | +21,674 (0.0%) | < 0.01% | $459,272 | 2023-05-11 |
Who else reported the position
183 managers reported DISC MEDICINE INC COM(DE) for Q2 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | Added | 3,245,710 | +21,329 | < 0.01% | $171,892,802 | 11 qtrs |
| Atlas Venture Life Science Advisors LLC | Unchanged | 2,384,456 | 0 | 19.07% | $126,280,790 | 11 qtrs |
| BlackRock Inc | Reduced | 2,044,827 | -49,733 | < 0.01% | $108,294,039 | 4 qtrs |
| Frazier Life Sciences Management L P | Reduced | 1,654,834 | -100,000 | 3.5% | $87,640,009 | 9 qtrs |
| RA CAPITAL MANAGEMENT L P | Unchanged | 1,577,106 | 0 | 1.41% | $83,523,534 | 2 qtrs |
| JANUS HENDERSON GROUP PLC | Added | 1,553,961 | +130,702 | 0.04% | $82,250,008 | 11 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Added | 1,515,625 | +157,371 | < 0.01% | $80,268,000 | 9 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 1,432,090 | -911,409 | 0.01% | $75,843,487 | 9 qtrs |
| ORBIMED ADVISORS LLC | Unchanged | 1,415,020 | 0 | 1.88% | $74,939,459 | 11 qtrs |
| VANGUARD GROUP INC | Added | 1,396,736 | +91,690 | < 0.01% | $73,971,138 | 11 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2025
- Filed
- August 14, 2025
- Filing type
- 13F-HR
- Position type
- CMN
Voting authority reported
- Sole
- 225,820
- Shared
- 0
- None
- 36
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.